Security key
60458C104
- Security type / class
- Equity / COM
- Total 13F shares
- 96,839
- Total 13F value
- $102,015
- Share change
- +96,039
- SEC-reported price per share
- $1.05
- Number of holders
- 6
- Value change
- +$100,725
- Number of buys
- 6
- Number of sells
- 2
Report period
Q4 2023
Institutions
6
Top holders
6
MIRA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
MIRA PHARMACEUTICALS, INC. SEC filings
MIRA PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 60458C104
Recent filing periods:
Ownership snapshot
Top reported holders of MIRA - MIRA PHARMACEUTICALS, INC. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
George Cappy
Disclosed value leader
George Cappy
Comparable rows
0/12
Latest evidence
15 Nov 2023
3/4/5
13F
Highest disclosed value: $4,474,748
12 rows are not safely comparable across share classes.
Showing 1-6 of 12 holder rows.
Quick read
George Cappy has the largest disclosed position value at $4.47M.
0 of 12 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens George Cappy's linked filing trail.
Disclosed position value
Top 5
George Cappy
$4.47M
Adam Kaplin
$310.8K
Bradley Kroenig
$77.7K
David C. Vorhoff
$62.2K
Hugh Mccoll III
$62.2K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 12 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| George Cappy |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$4,474,748
2,879,318 shares
|
— | 07 Aug 2023 |
| Bay Shore Trust |
3/4/5
10%+ Owner
|
—
class O/S missing
|
—
700,000 shares
|
— | 15 Nov 2023 |
| Adam Kaplin |
3/4/5
Pres. & Chief Scientific Off.
|
—
class O/S missing
|
$310,820
200,000 shares
|
— | 02 Aug 2023 |
| Bradley Kroenig |
3/4/5
Director
|
—
class O/S missing
|
$77,705
50,000 shares
|
— | 02 Aug 2023 |
| David C. Vorhoff |
3/4/5
Director
|
—
class O/S missing
|
$62,164
40,000 shares
|
— | 02 Aug 2023 |
| Hugh Mccoll III |
3/4/5
Director
|
—
class O/S missing
|
$62,164
40,000 shares
|
— | 02 Aug 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
96,839
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q1 2026 Across Filers
Q1 2026 holders
26
Q4 2023 holders
6
Holder diff
-20
| Investor | Q1 2026 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q1 2026 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend